U.S. Patent Disclosures
Thursday, February 16, 2012
Amorcyte Inc., of New York, received U.S. Patent No. 8,088,370, covering the use of AMR-001 in the repair of any vascular injury caused by vascular insufficiency.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.